WESTBROOK, Maine, May 28, 2014 /PRNewswire/ -- IDEXX
Laboratories, Inc. (NASDAQ: IDXX), announced today that it will
participate in the William Blair 34th Annual Growth
Stock Conference. Jonathan Ayers,
Chairman and Chief Executive Officer, is scheduled to make a
presentation on the Company on Tuesday, June
10, 2014 at 10:10 a.m. (Central
Time), at the Four Seasons Hotel, Chicago, Illinois. Individuals can access the
live audio webcast of the presentation through a link on the
homepage of the IDEXX Laboratories web site, www.idexx.com. An
archived edition of the presentation will be available for 14 days
via the same link.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in pet healthcare
innovation, serving practicing veterinarians around the world with
a broad range of diagnostic and information technology-based
products and services. IDEXX products enhance the ability of
veterinarians to provide advanced medical care, improve staff
efficiency and build more economically successful practices. IDEXX
is also a worldwide leader in providing diagnostic tests and
information for livestock and poultry and tests for the quality and
safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than
5,500 people and offers products to customers in over 175
countries.
Note Regarding Forward-Looking Statements
This news release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements are based on management's
current expectations and beliefs, as well as a number of
assumptions concerning future events. These statements are subject
to risks, uncertainties, assumptions and other important factors.
Readers are cautioned not to put undue reliance on such
forward-looking statements because actual results may vary
materially from those expressed or implied. The reports filed by
the Company pursuant to United
States securities laws contain discussions of these risks
and uncertainties. The Company assumes no obligation to, and
expressly disclaims any obligation to, update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise. Readers are advised to review the
Company's filings with the United States Securities and Exchange
Commission (which are available from the SEC's EDGAR database at
www.sec.gov, at various SEC reference facilities in the United States and via the Company's
website at www.idexx.com).
Contact: Bonnie Reid, Investor
Relations, (207) 556-8155, bonnie-reid@idexx.com
Logo -
http://photos.prnewswire.com/prnh/20110602/NE13041LOGO
SOURCE IDEXX Laboratories, Inc.